Contact this trialFirst, we need to learn more about you.
Nucleoside Reverse Transcriptase Inhibitor
TAF for Chronic Hepatitis B
Recruiting0 awardsPhase 2
Columbus, Ohio
This trial is testing a new drug, tenofovir alafenamide, to see if it is safe and effective in treating children and adolescents with chronic hepatitis B. The trial will consist of two parts, with the first part focused on collecting information about the new drug's pharmacokinetics in children, and the second part testing the safety and efficacy of the drug in children with chronic hepatitis B.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service